SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
dc.citation.volume | 7 | |
dc.contributor.author | Berzaghi, R. [UNIFESP] | |
dc.contributor.author | Maia, V. S. C. | |
dc.contributor.author | Pereira, F. V. | |
dc.contributor.author | Melo, F. M. [UNIFESP] | |
dc.contributor.author | Guedes, M. S. [UNIFESP] | |
dc.contributor.author | Origassa, C. S. T. | |
dc.contributor.author | Scutti, J. B. | |
dc.contributor.author | Matsuo, A. L. [UNIFESP] | |
dc.contributor.author | Camara, N. O. S. | |
dc.contributor.author | Rodrigues, E. G. [UNIFESP] | |
dc.contributor.author | Travassos, L. R. [UNIFESP] | |
dc.coverage | London | |
dc.date.accessioned | 2020-07-17T14:03:15Z | |
dc.date.available | 2020-07-17T14:03:15Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Silencing of SOCS1 protein with shRNAi lentivirus (shR-SOCS1) led to partial reversion of the tumorigenic phenotype of B16F10-Nex2 melanoma cells. SOCS1 silencing inhibited cell migration and invasion as well as in vitro growth by cell cycle arrest at S phase with increased cell size and nuclei. Down-regulation of SOCS1 decreased the expression of epidermal growth factor receptor, Ins-R alpha, and fibroblast growth factor receptors. The present work aimed at analyzing the SOCS1 cell signaling and expression of proteins relevant to tumor development. An RNA microarray analysis of B16F10-Nex2 melanoma cells with SOCS1 silenced by shRNAi-SOCS1 was undertaken in comparison with cells transduced with the empty vector. Among 609 differentially expressed genes, c-Kit, Met and EphA3 cytokine/tyrosine-kinase (TK) receptors were down regulated. A significant decrease in the expression of TK receptors, the phosphorylation of mediators of ERK1/2 and p38 pathways and STAT3 (S727) were observed. Subcutaneous immunization with shR-SOCS1-transduced viable tumor cells rendered protection against melanoma in a syngeneic model, with decreased expression of PD-L1 and of matrix metallo-proteinases (MMPs) and CD-10 in those cells. The present work shows the role of SOCS1 in murine melanoma development and the potential of SOCS1-silenced tumor cells in raising an effective anti-melanoma immune response. | en |
dc.description.affiliation | Univ Sao Paulo, Dept Microbiol Immunol & Parasitol, Expt Oncol Unit, Sao Paulo, Brazil | |
dc.description.affiliation | Recepta Biopharma Sao Paulo, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Sao Paulo, Lab Canc Immunobiol, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Immunol, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Texas MD Anderson Canc Ctr, Dept Immunol, Immunotherapy Platform, Houston, TX 77030 USA | |
dc.description.affiliation | Univ Fed Sao Paulo, Interdept Grp Hlth Econ Grides, Sao Paulo, SP, Brazil | |
dc.description.affiliation | Univ Sao Paulo, Biomed Sci Inst 4, Immunol Dept, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Immunol, Sao Paulo, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Interdept Grp Hlth Econ Grides, Sao Paulo, SP, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | State of Sao Paulo Foundation for Research Support (FAPESP) | |
dc.description.sponsorship | Brazilian National Council for Research and Development (CNPq) | |
dc.description.sponsorshipID | FAPESP: 2010/51423-0 | |
dc.description.sponsorshipID | FAPESP: 2012/17473-6 | |
dc.description.sponsorshipID | CNPq: 157559/2015-7 | |
dc.format.extent | - | |
dc.identifier | http://dx.doi.org/10.1038/srep40585 | |
dc.identifier.citation | Scientific Reports. London, v. 7, p. -, 2017. | |
dc.identifier.doi | 10.1038/srep40585 | |
dc.identifier.file | WOS000391664900001.pdf | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/55262 | |
dc.identifier.wos | WOS:000391664900001 | |
dc.language.iso | eng | |
dc.publisher | Nature Publishing Group | |
dc.relation.ispartof | Scientific Reports | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000391664900001.pdf
- Tamanho:
- 3.01 MB
- Formato:
- Adobe Portable Document Format
- Descrição: